BioSeek to support, advance Cellzome discovery projects
Cellzome vice president Biology Oliver Rausch said that the BioMAP platform will allow them to receive early insight into the human pharmacological and toxicological properties of theeir small

Cellzome vice president Biology Oliver Rausch said that the BioMAP platform will allow them to receive early insight into the human pharmacological and toxicological properties of theeir small

As per the extended agreement, Pfizer is expected to continue to fund all aspects of the collaboration including research efforts at both companies and all clinical development costs

Bardoxolone methyl, which is currently in late Phase 2 trials, is an oral, antioxidant inflammation modulator that works by increasing the estimated glomerular filtration rate (eGFR) of the

Menerba is an oral, botanically-derived estrogen receptor beta (ER-b) selective drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause. With this

Additionally, a pharmacokinetic study was presented, which investigated linagliptin in a special patient population with different degrees of renal impairment. Linagliptin belongs to the new class of DPP-4

Most recently, McElroy has worked with Chiltern International for over two years as the executive director of Strategic Development, Americas. Before joining Chiltern, he served as the vice

The Promus Element Stent features a new Platinum chromium (PtCr) alloy and new stent design, which combine to offer greater radial strength and flexibility while reducing stent recoil.

Catalyst Pharma is currently conducting a number of non-clinical safety and efficacy studies with CPP-115 to support various indications and expects to file an IND with respect to

Winton will report to Bart Peterson, senior vice president, Corporate Affairs and Communications. Winton is expected to take up the responsibility for Communications across Lilly, including oversight of

Glatiramer acetate is an immunomodulator drug for currently used to treat multiple sclerosis. Copaxone is a random polymer of four amino acids found in myelin basic protein, namely